grant

PROVIDENT: Prepositioning Optimized Strategies for Vaccines and Immunotherapeutics against Diverse Emerging Infectious Threats

Organization ALBERT EINSTEIN COLLEGE OF MEDICINELocation BRONX, UNITED STATESPosted 1 Sept 2024Deadline 30 Jun 2029
NIHUS FederalResearch GrantFY2025Ab-mediated immunityAb-mediated protectionAcademiaAchievementAchievement AttainmentAdvanced DevelopmentAnimal ModelAnimal Models and Related StudiesAnimalsAntibodiesAntibody RepertoireAntibody ResponseAntibody immunityAntibody protectionAntibody-mediated protectionAntigensAssayBioassayBiologicalBiological AssayBispecific Monoclonal AntibodiesBlood VesselsBunyavirusCell BodyCell Surface AntigensCellsCellular ImmunologyCollaborationsComplementComplement ProteinsCritical PathsCritical PathwaysData Management CoreDevelopmentDiseaseDisease OutbreaksDisorderDissectionDoseEngineeringEvaluationEventExerciseFamilyFutureGeneticGenotypeGlycoproteinsGoalsGovernmentHantavirusHost FactorHost Factor ProteinHumanImmune responseImmunizeImmunochemical ImmunologicImmunologicImmunologicalImmunological Surface MarkersImmunologicallyImmunologicsImmunotherapeutic agentIndustryInfectionInstitutionIntegration Host FactorsKnowledgeLeadMapsMiningModern ManMolecularNairovirusNon-Polyadenylated RNAOrthobunyavirusOrthohantavirusesOrthonairovirusOutbreaksParamyxoviridaeParamyxovirusPathogenesisPathogenicityPathway interactionsPb elementPhasePlayPositionPositioning AttributeProteinsProteomicsR-Series Research ProjectsR01 MechanismR01 ProgramRNARNA Gene ProductsRNA VirusesRNA vaccineRNA-based vaccineReceptor ProteinRecombinantsRegulatory approvalResearchResearch GrantsResearch Project GrantsResearch ProjectsRibonucleic AcidRisk AssessmentSafetySeriesSerotypingStructureSurface AntigensT cell responseTestingTherapeuticTherapeutic UsesTherapeutic antibodiesToxinTransgenic AnimalsVaccinationVaccine DesignVaccinesValidationViralViral DiseasesViral PathogenesisVirusVirus Diseasesantibody-mediated immunitybi-specific monoclonal antibodiesbiologicclinical translationclinically translatablecommercializationcomplementationdata management and coordinating centerdata management centerdesigndesigningdevelop a vaccinedevelop vaccinesdevelopment of a vaccinedevelopmentalendothelial dysfunctionepidemic concernepidemic potentialepidemic riskepidemic threatexperimentexperimental researchexperimental studyexperimentsheavy metal Pbheavy metal leadhost responseimmune drugsimmune system responseimmune-based therapeuticsimmunogenimmunogenicityimmunologic therapeuticsimmunoresponseimmunotherapeuticsimmunotherapy agentin vivoindustrial partnershipindustry partnerindustry partnershipmRNA vaccinemRNA-based vaccinemembermodel of animalnon-human primatenonhuman primatepandemic concernpandemic potentialpandemic riskpandemic threatpathwayprophylacticprotective efficacyprototypereceptorregulatory authorizationregulatory certificationregulatory clearanceresponserisk mitigationsafety assessmentstructural biologytoolvaccine antibodiesvaccine developmentvaccine induced antibodiesvaccine platformvaccine strategyvaccine-induced antibodiesvalidationsvascularviral infectionviral infection mechanismvirologyvirus host interactionvirus infectionvirus infection mechanismvirus pathogenesisvirus-induced disease
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

The overarching goal of PROVIDENT (Prepositioning Optimized Strategies for Vaccines and Immunotherapeu-
tics against Diverse Emerging Infectious Threats) is to deliver “plug-and-play” vaccine and therapeutic an-

tibody blueprints for emerging enveloped RNA viruses belonging to three families—Nairoviridae, Han-

taviridae, and Paramyxoviridae.…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →